OTCMKTS:SHWZ Medicine Man Technologies (SHWZ) Stock Price, News & Analysis $0.02 +0.02 (+769.57%) As of 08/6/2025 03:53 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsBuy This Stock About Medicine Man Technologies Stock (OTCMKTS:SHWZ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SHWZ alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.00▼$0.0352-Week Range$0.00▼$0.30Volume7,335 shsAverage Volume9,268 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$2.50Consensus RatingBuy Company Overview Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado. Read More Receive SHWZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicine Man Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address SHWZ Stock News HeadlinesMedicine Man Technologies Faces Leadership Change Amid Financial ChallengesDecember 14, 2024 | markets.businessinsider.comNoble Financial Sticks to Their Buy Rating for Medicine Man Technologies (SHWZ)December 10, 2024 | markets.businessinsider.comMarket Crash Warning: How to Protect Your Wealth Before August 12thNew China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shifting out of stocks, while everyday investors remain exposed. A free guide reveals where the smart money is going—and how to protect your wealth before the next sell-off. | American Alternative (Ad)Schwazze Provides Update on Delayed FilingsDecember 4, 2024 | globenewswire.comSchwazze's Q3 Preliminary Revenue Slides As Debt Grows, 2023 Financials Face Re-AuditNovember 8, 2024 | benzinga.comSchwazze Announces Preliminary Third Quarter 2024 Financial ResultsNovember 7, 2024 | finance.yahoo.comBrain Tech Is Here and Not as Creepy as You ThinkNovember 1, 2024 | bloomberg.comUW Medicine using newest robotics tech in spinal surgeryOctober 22, 2024 | msn.comSee More Headlines SHWZ Stock Analysis - Frequently Asked Questions How have SHWZ shares performed this year? Medicine Man Technologies' stock was trading at $0.02 at the beginning of 2025. Since then, SHWZ shares have increased by 0.0% and is now trading at $0.02. How do I buy shares of Medicine Man Technologies? Shares of SHWZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medicine Man Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medicine Man Technologies investors own include NVIDIA (NVDA), Westmoreland Coal (WLB), Advanced Micro Devices (AMD), Pfizer (PFE), Meta Platforms (META), PayPal (PYPL) and Taiwan Semiconductor Manufacturing (TSM). Company Calendar Today8/06/2025Next Earnings (Estimated)8/11/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryBusiness Services Current SymbolOTCMKTS:SHWZ Previous SymbolOTC:SHWZ CIK1622879 Webwww.schwazze.com Phone(303) 371-0387FaxN/AEmployees390Year FoundedN/APrice Target and Rating Average Price Target for Medicine Man Technologies$2.50 High Price Target$2.50 Low Price Target$2.50 Potential Upside/Downside+12,400.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:SHWZ) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicine Man Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicine Man Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.